Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
28th ISCP Annual Scientific Meeting
23rd - 25th November 2023
It is our great privilege and pleasure to cordially invite all of you to our upcoming 28th ISCP 2023 in Seoul, South Korea.
The scientific meeting is jointly organized by ISCP (International Society of Cardiovascular Pharmacotherapy), KSCVP (Korean Society of Cardiovascular Pharmacotherapy), and KSCP (Korean Society of Cardiovascular Disease Prevention).
The organizing committee has decided to hold ISCP 2023 Seoul in a hybrid format, delivering both in-person and online meetings. ISCP 2023 Seoul will provide key insight, practice-changing updates, and cutting-edge educational content with outstanding world-class professionals. It brings together key stakeholders in all areas of cardiovascular pharmacotherapies, cardiovascular disease prevention, and better patient care. It is our pride, privilege, and pleasure to keep highly educational communications transpiring through ISCP 2023 Seoul.
For more details on the event’s venue, registration process, and preliminary programme please visit the meeting’s website >> https://iscp2023.org
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
Our first five webinars produced in collaboration with our partners Radcliffe Cardiology are now available to view in the Webinars On Demand section:
1- Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure-Related Readmissions,
2- Inclisiran: A Jab Goes a Long Way,
3- Edoxaban: ENGAGEing in Individualisation of DOACs,
4- Valsartan Sacubitril: Has our PARADIGM shifted?,
5- Clopidogrel or Ticagrelor: Why, When, for Whom?, and
Details of future webinars will become available in Upcoming webinars very soon, including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
FDA approves Jardiance to treat adults with CKD
Posted on September 22, 2023
The FDA approved Jardiance 10 mg tablets to lower the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death and... more
Cardiology ‘has evolved’: Heart societies unite to push for independent medical board
Posted on September 22, 2023
Four professional cardiovascular societies announced a push to create an independent board for cardiovascular medicine, part of an effort to simplify a... more
Household income, parental education impact health intervention effects for preschoolers
Posted on September 22, 2023
Preschool-aged children of lower socioeconomic status have poorer health and derive less benefit from the same lifestyle interventions delivered to preschoolers of... more
Persistent AF independently predicts poor outcomes after catheter ablation
Posted on September 22, 2023
Persistent atrial fibrillation was associated with worse outcomes and less quality of life benefit after catheter ablation compared with paroxysmal AF, researchers... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
VP / President Elect
Affiliations/Memberships Founder and Past President of the Argentine Lipids Society (2003-2005); Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS). Research Interests Atherosclerosis Lipid Metabolism Inflammation and CHD more
-
Pablo Avanzas
Secretary
Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more
-
Sang Hong Baek
President
Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more
-
Georg Noll
Treasurer
Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more